What do companies such as Twitter, Facebook, and Google have in common with Pfizer, Amgen, BioMarin, Alkermes, and Jazz Pharmaceuticals? Dublin. All of them have set up international operations in Dublin, in…
Some members of the media are ebullient with the news that Merck is "getting into venture capital." However, as In Vivo is reporting, Merck is undertaking two initiatives that are…
Lacerta Bio was fortunate to attend this year's BioPharm America conference in Boston. Here are a few of our comments and observations: Are Specialty Markets the Future? - Moderated by…
Yesterday's Financial Times reported that pharmacists in Spain are struggling to continue operating their businesses due to a lack of payment from the Regional governments. “We depend 80 to 90…
GSK announced that it has taken a ~25% stake in a new spin out. This is a terrific way to create new companies and advance more molecules into the clinic,…
On the one hand, you hate to see talent leaving the US. But, you have to applaud their attitude: "Although we are comfortable in America, we often felt that something…
Posts have been light lately, due to vacations, summer hours, etc. However, we've remained busy with client work and keeping up with the news. A few recent news items of…
Today's New England Journal of Medicine contains a short article by Kozlowski et al entitled Developing the Nation's Biosimilars Program (link to PDF). Here, the authors attempt t provide a…
As we were wrapping up our annual July vacation, we were shocked to hear about the magnitude of job cuts at Merck. This is on top of the 11,500 jobs Merck cut…
As FiercePharma correctly points out, GSK's Q II report reflects the overall industry trends quite accurately: The rest of Glaxo's report, like the rest of Big Pharma's Q2 results so…